University of Rijeka, Croatia (Hrvatska)
Dr Mirela Sedic is Associate Professor at the University of Rijeka Department of Biotechnology in Croatia. She is author or co-author of more than 30 scientific publications in peer-reviewed journals including high-impact journals such as Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, and Cancer Treatment Reviews. She is also co-author of book chapters in Bioinformatics and Drug Discovery (Humana Press, 2012), Personalized Medicine: A New Medical and Social Challenge
(Springer International Publishing, 2016), and has one international patent (WO/2010/052510). Her work has been cited 755 times (h-index 14; i10-index 18). She was a reviewer for several international scientific journals including Hormone and Metabolic Research, Journal of Cancer Research and Clinical Oncology, Bioinformatics and Biology Insights, Polycyclic Aromatic Compounds and Current Medicinal Chemistry. She is also a member of Editorial Board of the International Journal of Biotechnology & Bioengineering and Global Journal of Cancer Therapy. She has co-authored the paper “Metastasis: new perspectives on an old problem” in Molecular Cancer in 2011, which was ranked among the top 20 most viewed articles in 2013. She was also co-author of the paper “Proteomics in antitumor research” in Drug Discovery Today: Technologies (2006), which was ranked among the Top 25 Hottest Articles in Pharmacology, Toxicology and Pharmaceutical Science) by Elsevier (ScienceDirect) in 2007. Her main research interests include cancer biology and treatment, bioactive sphingolipids in anti-cancer therapy, and application of proteomics technology to biomedical research.